Financials
- Market Capitalization 121.64 M
- Employee 5
- Founded 2005
- CEO N/A
- Website www.neonc.com
- Headquarter Delaware, United States
- FIGI BBG01KPDB522
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.18
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3850 | ENGN enGene Therapeutics Inc. - Common Stock | 1.83 USD | -4.19% | +2.23% | +2.23% | -78.21% | 122.59 M USD | ||
| 3852 | TLSA Tiziana Life Sciences Ltd - Common Shares | 1.01 USD | -6.48% | -11.40% | +1.00% | -43.26% | 121.71 M USD | ||
| 3855 | PMN ProMIS Neurosciences Inc. - Common Shares | 13.47 USD | -3.72% | -6.13% | -1.46% | +2394.44% | 120.79 M USD | ||
| 3859 | GNLX Genelux Corporation - Common Stock | 2.66 USD | -7.64% | -1.48% | -10.44% | -19.39% | 120.35 M USD |